Paper41883166
Stabilized mosaic hemagglutinin immunogens as novel universal influenza virus vaccines.
Mishra M and 13 others. Mol Ther, 2026. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Stabilized mosaic hemagglutinin immunogens as novel universal influenza virus vaccines. Papers, record 41883166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41883166
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Influenza Vaccines | Major topic |
| Hemagglutinin Glycoproteins, Influenza Virus | Major topic |
| Orthomyxoviridae Infections | Major topic |
| Influenza, Human | Major topic |
| Animals | |
| Mice | |
| Antibodies, Viral | |
| Humans | |
| Female | |
| Protein Subunit Vaccines | |
| Antibodies, Neutralizing | |
| Vaccination | |
| Protein Stability |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 75N93019C00051 | NIH HHS | United States | PubMed | PubMed | |
| 75N93021C00014 | NIH HHS | United States | PubMed | PubMed | |
| P01 AI097092 | NIAID NIH HHS | United States | P01AI097092 | PubMed | NIH RePORTER |
| R01 AI145870 | NIAID NIH HHS | United States | R01AI145870 | PubMed | NIH RePORTER |
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31871236 | Influenza Hemagglutinin Structures and Antibody Recognition. | Cold Spring Harb Perspect Med | 2020 | https://conductscience.org/library/papers/31871236 | PubMed |
| 2 | 34942633 | Broadly neutralizing antibodies target a haemagglutinin anchor epitope. | Nature | 2022 | https://conductscience.org/library/papers/34942633 | PubMed |
| 3 | 29263881 | A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies. | NPJ Vaccines | 2017 | https://conductscience.org/library/papers/29263881 | PubMed |
| 4 | 23978327 | Influenza virus hemagglutinin stalk-based antibodies and vaccines. | Curr Opin Virol | 2013 | https://conductscience.org/library/papers/23978327 | PubMed |
| 5 | 39369576 | Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact. | Vaccine | 2024 | https://conductscience.org/library/papers/39369576 | PubMed |
| 6 | 39567664 | A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses. | Nat Microbiol | 2024 | https://conductscience.org/library/papers/39567664 | PubMed |
| 7 | 22928001 | A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates. | PLoS One | 2012 | https://conductscience.org/library/papers/22928001 | PubMed |
| 8 | 37679361 | A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses. | NPJ Vaccines | 2023 | https://conductscience.org/library/papers/37679361 | PubMed |
| 9 | 30715353 | Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain. | J Infect Dis | 2019 | https://conductscience.org/library/papers/30715353 | PubMed |
| 10 | 36542692 | A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/36542692 | PubMed |
| 11 | 31771231 | Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in Mice. | Vaccines (Basel) | 2019 | https://conductscience.org/library/papers/31771231 | PubMed |
| 12 | 34078743 | First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/34078743 | PubMed |
| 13 | 39241354 | A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters. | Vaccine | 2024 | https://conductscience.org/library/papers/39241354 | PubMed |
| 14 | 33232870 | Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate. | EBioMedicine | 2020 | https://conductscience.org/library/papers/33232870 | PubMed |
| 15 | 37342504 | Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/37342504 | PubMed |
| 16 | 38982712 | Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. | Hum Vaccin Immunother | 2024 | https://conductscience.org/library/papers/38982712 | PubMed |
| 17 | 34999208 | A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice. | Mol Ther | 2022 | https://conductscience.org/library/papers/34999208 | PubMed |
| 18 | 35848945 | An In Vitro Microneutralization Assay for Influenza Virus Serology. | Curr Protoc | 2022 | https://conductscience.org/library/papers/35848945 | PubMed |
| 19 | 31341648 | A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains. | NPJ Vaccines | 2019 | https://conductscience.org/library/papers/31341648 | PubMed |
| 20 | 25635058 | Immunosilencing a highly immunogenic protein trimerization domain. | J Biol Chem | 2015 | https://conductscience.org/library/papers/25635058 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41883166
GET https://conductscience.org/api/papers/v1/41883166/references?page=2